| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |